leadf
logo-loader
viewHeartseed

Heartseed developing heart failure treatment

Heartseed Inc CEO Keiichi Fukuda sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Tokyo-based biotechnology company is developing a treatment for heart failure, and recently raised $26M in Series B funding.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Metal Tiger on Kitlanya East copper-silver project progress and oncoming...

Metal Tiger PLC's (LON:MTR) Michael McNeilly catches up with Proactive London's Katie Pilbeam after reporting progress at the Kitlanya East copper-silver project in Botswana, operated by Kalahari Metals Ltd (KML). McNeilly explains the potential for the South Fold target to host copper-silver...

1 day, 22 hours ago

2 min read